Protective versus Pathogenic Type I Interferon Responses during Virus Infections
Viruses · 13.09.2023 · 15 (9) · 1916
DOI: 10.3390/v15091916 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 13.09.2023. Verfasst von Kwang Il Jung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Surgery & Molecular Microbiology and Immunology, University of Missouri, Columbia, MO 65212, USA. Hauptthemen laut MEDLINE: Interferon Type I, COVID-19, Virus Diseases. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH/NIAID.
Abstract (Originalsprache)
Following virus infections, type I interferons are synthesized to induce the expression of antiviral molecules and interfere with virus replication. The importance of early antiviral type I IFN response against virus invasion has been emphasized during COVID-19 as well as in studies on the microbiome. Further, type I IFNs can directly act on various immune cells to enhance protective host immune responses to viral infections. However, accumulating data indicate that IFN responses can be harmful to the host by instigating inflammatory responses or inducing T cell suppression during virus infections. Also, inhibition of lymphocyte and dendritic cell development can be caused by type I IFN, which is independent of the traditional signal transducer and activator of transcription 1 signaling. Additionally, IFNs were shown to impair airway epithelial cell proliferation, which may affect late-stage lung tissue recovery from the infection. As such, type I IFN–virus interaction research is diverse, including host antiviral innate immune mechanisms in cells, viral strategies of IFN evasion, protective immunity, excessive inflammation, immune suppression, and regulation of tissue repair. In this report, these IFN activities are summarized with an emphasis placed on the functions of type I IFNs recently observed during acute or chronic virus infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Surgery & Molecular Microbiology and Immunology, University of Missouri, Columbia, MO 65212, USA.
ORCID-Profile: Bumsuk Hahm
Förderung
- NIAID NIH HHS
- NIH/NIAID
Zitieren
APA
Jung, K. I., McKenna, S., Vijayamahantesh, V., He, Y., & Hahm, B. (2023). Protective versus Pathogenic Type I Interferon Responses during Virus Infections. Viruses, 15(9), 1916. https://doi.org/10.3390/v15091916
Vancouver
Jung KI, McKenna S, Vijayamahantesh V, He Y, Hahm B. Protective versus Pathogenic Type I Interferon Responses during Virus Infections. Viruses. 2023;15(9):1916. doi:10.3390/v15091916
BibTeX
@article{Jung2023,
author = {Jung, Kwang Il and McKenna, Savannah and Vijayamahantesh, Vijayamahantesh and He, Ying and Hahm, Bumsuk},
title = {Protective versus Pathogenic Type I Interferon Responses during Virus Infections},
journal = {Viruses},
year = {2023},
volume = {15},
number = {9},
pages = {1916},
doi = {10.3390/v15091916}
}
EUVIMED